Health Trials

Transcranial Magenetic Stimualtion

2

Review clinical trials related to Transcranial Magenetic Stimualtion. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and widely used neuromodulation technology. Small sample studies have shown that rTMS treatment can significantly improve the symptoms of Parkinson's disease(PD) and delay the progression of the disease. In order to further explore the effectiveness of rTMS in the treatment of PD and lay the foundation for its clinical promotion, our research team plans to conduct a randomized double-blind controlled study of rTMS in the treatment of PD in multiple centers across the country.

Participants needed: 290
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: Anhui Medical UniversityUpdated: Jun 17, 2025Locations: 1
Eligibility criteria

Age ≥ 40 years old; [+4]

Previously head MRI/CT was focal brain injury or severe leukoencephalopathy (Faz... [+9]

Read more
Status: Not yet recruiting

The Efficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease：A Randomized, Double-blind, Multicenter, Placebo-controlled Trial

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and widely used neuromodulation technology. Small sample studies have shown that rTMS treatment can significantly improve the symptoms of Parkinson's disease(PD) and delay the progression of the disease. In order to further explore the effectiveness of rTMS in the treatment of PD and lay the foundation for its clinical promotion, our research team plans to conduct a randomized double-blind controlled study of rTMS in the treatment of PD in multiple centers across the country.

Participants needed: 312
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: Anhui Medical UniversityUpdated: Sep 4, 2024
Eligibility criteria

Age ≥40 years old [+4]

Head MRI/CT ruled out focal brain injury or severe leukoencephalopathy (Fazekas... [+9]

Read more